Skip Navigation


JAC Advance Access originally published online on November 11, 2008
Journal of Antimicrobial Chemotherapy 2009 63(1):72-79; doi:10.1093/jac/dkn463
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
63/1/72    most recent
dkn463v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Suzuki, S.
Right arrow Articles by Arakawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, S.
Right arrow Articles by Arakawa, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread

Satowa Suzuki1,*, Naohiro Shibata1, Kunikazu Yamane1, Jun-ichi Wachino1, Kenitiro Ito2 and Yoshichika Arakawa1

1 Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, 4-7-1 Musashi-murayama, Tokyo 208-0011, Japan 2 Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, 4-7-1 Musashi-murayama, Tokyo 208-0011, Japan

Received 23 July 2008; returned 5 September 2008; revised 14 October 2008; accepted 14 October 2008


* Corresponding author. Tel: +81-42-561-0771; Fax: +81-42-561-7173; E-mail: suzukiss{at}nih.go.jp

Introduction: In the early 2000s, there was a rapid increase in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in hospital settings throughout Japan. The reasons for this rapid increase are unclear.

Methods: Between 2002 and 2003, 142 clinical isolates of E. coli suspected of producing ESBL were obtained from 37 hospitals and commercial clinical laboratories in geographically distinct regions throughout Japan. They were tested for ESBL types and further subtyped for serogroups, fimH single nucleotide polymorphism, pulsed-field gel electrophoresis patterns and multilocus sequence type (MLST). Representative isolates were also subjected to plasmid analysis.

Results: Of 142 E. coli isolates suspected of producing ESBL, 130 were confirmed as harbouring blaCTX-M by PCR analysis and sequencing. Of these, 84 (65%) harboured CTX-M-9-group blaCTX-M. Two serogroups O25 and O86 accounted for 41% of the 130 blaCTX-M-positive E. coli. All O86 serogroup strains belonged to ST38 by MLST and they formed 18% of all the blaCTX-M-positive E. coli. Serogroup O25 strains belonged to ST131 and ST73, and formed 21% and 1% of blaCTX-M-positive E. coli, respectively. Seven characterized plasmids carrying blaCTX-M genes belonged to three distinct incompatibility groups: IncF, IncN and IncI1.

Conclusions: In this study, clonally related strains of E. coli accounted for a large proportion of blaCTX-M-positive E. coli. This high proportion of clonal groups identified in different regions of Japan suggests their recent spread by mechanisms other than healthcare-associated transmission. These observations imply that restricting antimicrobial use in human clinical settings may have limited impact on the spread of ESBL-producing E. coli.

Keywords: E. coli , ESBLs , CTX-M


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A. Valverde, R. Canton, M. P. Garcillan-Barcia, A. Novais, J. C. Galan, A. Alvarado, F. de la Cruz, F. Baquero, and T. M. Coque
Spread of blaCTX-M-14 Is Driven Mainly by IncK Plasmids Disseminated among Escherichia coli Phylogroups A, B1, and D in Spain
Antimicrob. Agents Chemother., December 1, 2009; 53(12): 5204 - 5212.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. E. Sidjabat, D. L. Paterson, J. M. Adams-Haduch, L. Ewan, A. W. Pasculle, C. A. Muto, G.-B. Tian, and Y. Doi
Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania
Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4733 - 4739.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Woodford, A. Carattoli, E. Karisik, A. Underwood, M. J. Ellington, and D. M. Livermore
Complete Nucleotide Sequences of Plasmids pEK204, pEK499, and pEK516, Encoding CTX-M Enzymes in Three Major Escherichia coli Lineages from the United Kingdom, All Belonging to the International O25:H4-ST131 Clone
Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4472 - 4482.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
O. Clermont, H. Dhanji, M. Upton, T. Gibreel, A. Fox, D. Boyd, M. R. Mulvey, P. Nordmann, E. Ruppe, J. L. Sarthou, et al.
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains
J. Antimicrob. Chemother., August 1, 2009; 64(2): 274 - 277.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. D. D. Pitout, D. B. Gregson, L. Campbell, and K. B. Laupland
Molecular Characteristics of Extended-Spectrum-{beta}-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2846 - 2851.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
L. F. Mataseje, N. Neumann, B. Crago, P. Baudry, G. G. Zhanel, M. Louie, M. R. Mulvey, and and the ARO Water Study Group
Characterization of Cefoxitin-Resistant Escherichia coli Isolates from Recreational Beaches and Private Drinking Water in Canada between 2004 and 2006
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3126 - 3130.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Blanco, M. P. Alonso, M.-H. Nicolas-Chanoine, G. Dahbi, A. Mora, J. E. Blanco, C. Lopez, P. Cortes, M. Llagostera, V. Leflon-Guibout, et al.
Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15
J. Antimicrob. Chemother., June 1, 2009; 63(6): 1135 - 1141.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.